DIANE CLUTE: Open Payments
NPI 1174017297 · VERONA, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$213 in 11 payments from 8 companies in 2025. Trend: 2023 $303 · 2024 $68 · 2025 $213
Food & beverage: $213
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $42 |
| Merck Sharp & Dohme LLC | 2 | $35 |
| PFIZER INC. | 2 | $34 |
| Madrigal Pharmaceuticals | 1 | $32 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
Products named: ELIQUIS, REZDIFFRA, Ozempic, JOURNAVX, Wegovy, GARDASIL 9, SHINGRIX, LAGEVRIO.
Industry payments across NY — which companies pay providers there.
